Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04817566 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment

Study acronym: NeuroMod-PCCI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 4, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Jun 2024 to Jun 2026
    • Study completion date: Aug 2024 to Jun 2026
    • Eligibility criteria expanded, about 1 word
    v4
  2. Notable Primary completion date: Jun 2023 to Jun 2024
    • Study completion date: Aug 2023 to Aug 2024
    v3
  3. Notable Phase: Phase 2 to Not applicablev2 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2021 to Nov 2, 2021
    • Enrollment target: 40 to 52
    • Site details revised
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate whether a high definition tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in women with post-chemotherapy cognitive impairment after breast cancer treatment.
Trial Details
NCT Number NCT04817566
Lead Sponsor University Medicine Greifswald
Collaborators: University of Greifswald
Conditions
(from sponsor)
Breast Cancer, Cognitive Impairment
Related terms Breast Neoplasms, Cognitive Dysfunction
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov